25G-NBOMe

From English Wikipedia @ Freddythechick
(Redirected from 2C-G-NBOMe)
25G-NBOMe
Clinical data
ATC code
  • none
Legal status
Legal status
Identifiers
  • 2-(2,5-dimethoxy-3,4-dimethylphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC20H27NO3
Molar mass329.440 g·mol−1
3D model (JSmol)
  • CC1=C(C=C(C(=C1C)OC)CCNCC2=CC=CC=C2OC)OC
  • InChI=1S/C20H27NO3/c1-14-15(2)20(24-5)16(12-19(14)23-4)10-11-21-13-17-8-6-7-9-18(17)22-3/h6-9,12,21H,10-11,13H2,1-5H3
  • Key:VDAUMFACIMNTDA-UHFFFAOYSA-N

25G-NBOMe (NBOMe-2C-G) is a derivative of the phenethylamine hallucinogen 2C-G, which acts as a highly potent agonist for the human 5-HT2A receptor.[1]

Toxicity and harm potential

Page '25-NB' not found

Neurotoxic and cardiotoxic actions

Page '25-NB' not found

Emergency treatment

Page '25-NB' not found

Legality

Sweden

The Riksdag added 25G-NBOMe to Narcotic Drugs Punishments Act under swedish schedule I ("substances, plant materials and fungi which normally do not have medical use") as of January 16, 2015, published by Medical Products Agency (MPA) in regulation LVFS 2014:11 listed as 25G-NBOMe, and 2-(2,5-dimetoxi-3,4-dimetylfenyl)-N-(2-metoxibensyl)etanamin.[2]

United Kingdom

This substance is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.[3]

See also

Notes

References

  1. ^ Chloe B, Alexander G, John M (2017). "Acute Toxicity Related to 25G-NBOMe Use: An Internet High". Journal of Acute Medicine. 7 (1): 40–43. doi:10.6705/j.jacme.2017.0701.007. PMC 7517925. PMID 32995169.
  2. ^ "Föreskrifter om ändring i Läkemedelsverkets föreskrifter (LVFS 2011:10) om förteckningar över narkotika" [Regulations on changes in the Swedish Medicines Agency's regulations (LVFS 2011:10) on lists of narcotics] (PDF). Läkemedelsverkets författningssamling [The Swedish Medicines Agency's constitution collection] (in svenska). 22 December 2014. Archived from the original (PDF) on 2015-03-16. Retrieved 2017-04-21.
  3. ^ "The Misuse of Drugs Act 1971 (Ketamine etc.) (Amendment) Order 2014". UK Statutory Instruments 2014 No. 1106. www.legislation.gov.uk.